Extramedullary Relapse of Acute Myelogenous Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Better Prognosis Than Systemic Relapse

Biology of Blood and Marrow Transplantation

Volumn 18, Issue 1, 2012, Pages 106-112

  Solh, Melhem ^a   DeFor, Todd E ^b   Weisdorf, Daniel J ^a   Kaufman, Dan S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Extramedullary; Leukemia; Relapse; Transplantation

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOSPORIN; CYTARABINE; FLUDARABINE; GEMTUZUMAB OZOGAMICIN; HYDROXYUREA; METHOTREXATE; MYCOPHENOLIC ACID;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BONE CANCER; BONE MARROW CANCER; BRAIN TUMOR; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; COHORT ANALYSIS; DUODENUM CANCER; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; INFANT; JEJUNUM CANCER; LEUKEMIA RELAPSE; LOCAL THERAPY; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM CANCER; PAROTID GLAND CANCER; PELVIS CANCER; PHARYNX CANCER; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCHOOL CHILD; SKIN CANCER; SPINAL CORD TUMOR; SYSTEMIC THERAPY; UROGENITAL TRACT CANCER;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; LEUKEMIA, MYELOID, ACUTE; LEUKEMIC INFILTRATION; MIDDLE AGED; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84855432900     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2011.05.023     Document Type: Article

References (34)

1. Burnett A., Wetzler M., Lowenberg B. Therapeutic advances in acute myeloid leukemia. J Clin Oncol 2011, 29:487-494.
2. Schlenk R.F., Dohner K., Mack S., et al. Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98A. J Clin Oncol 2010, 28:4642-4648.
3. Giralt S.A., Champlin R.E. Leukemia relapse after allogeneic bone marrow transplantation: a review. Blood 1994, 84:3603-3612.
4. Zittoun R.A., Mandelli F., Willemze R., et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups. N Engl J Med 1995, 332:217-223.
5. Schlenk R.F., Dohner K., Krauter J., et al. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. NEngl J Med 2008, 358:1909-1918.
6. Lee K.H., Lee J.H., Choi S.J., et al. Bone marrow vs extramedullary relapse of acute leukemia after allogeneic hematopoietic cell transplantation: risk factors and clinical course. Bone Marrow Transplant 2003, 32:835-842.
7. Cunningham I. Extramedullary sites of leukemia relapse after transplant. Leuk Lymphoma 2006, 47:1754-1767.
8. Kikushige Y.K., Takase K., Sata K., et al. Repeated relapses of acute myelogenous leukemia in the isolated extramedullary sites following allogeneic bone marrow transplantations. Intern Med 2007, 46:1011-1014.
9. Oshima K., Kanda Y., Yamashita T., et al. Central nervous systemrelapse of leukemia after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2008, 14:1100-1107.
10. Schafer H., Bader P., Kaiserling E., et al. Extramedullary relapses at uncommon sites after allogeneic stem cell transplantation. Bone Marrow Transplant 2000, 26:1133-1135.
11. Bekassy A.N., Hermans J., Gorin N.C., et al. Acute and Chronic Leukemia Working Parties of the European Group for Blood and Marrow Transplantation. Granulocytic sarcoma after allogeneic bone marrow transplantation: a retrospective European multicenter survey. Bone Marrow Transplant 1996, 17:801-808.
12. Fleming D.R., Greenwood M.E., Garrison J., et al. Lymphocyte infusion for delayed extramedullary relapse of acute leukemia following bone marrow transplantation. Leuk Lymphoma 1996, 21:525-528.
13. De la Camara R., Figuera A., Steegmann J.L., et al. Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia. Results from a single institution. Bone Marrow Transplant 1992, 9:433-438.
14. Michel G., Boulad F., Small T.N., et al. Risk of extramedullary relapse following allogeneic bone marrow transplantation for acute myelogenous leukemia with leukemia cutis. Bone Marrow Transplant 1997, 20:107-112.
15. Riseberg D.A., Mulvey K.P., Dahut W.L., et al. Late extramedullary relapse following bone marrow transplant for AML presenting as acute renal failure and leukemic ascites. Bone Marrow Transplant 1994, 14:1009-1010.
16. Au W.Y., Kwong Y.L., Lie A.K., et al. Extra-medullary relapse of leukemia following allogeneic bone marrow transplantation. Hematol Oncol 1999, 17:45-52.
17. Lee K.H., Lee J.H., Kim S., et al. High frequency of extramedullary relapse of acute leukemia after allogeneic bone marrow transplantation. Bone Marrow Transplant 2000, 26:147-152.
18. Barker J.N., Weisdorf D.J., DeFor T.E., et al. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 2003, 102:1915-1959.
19. Lin D.Y. Non-parametric inference for cumulative incidence functions in competing risks studies. Stat Med 1997, 16:901-910.
20. Koreth J., Schlenk R., Kopecky K.J., et al. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials. JAMA 2009, 301:2349-2361.
21. Sierra J., Storer B., Hansen L.A., et al. Unrelated donor marrow transplantation for acute myeloid leukemia: an update of theSeattle experience. Bone Marrow Transplant 2000, 26:397-404.
22. Aoudjhane M., Labopin M., Gorin N.C., et al. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA-identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT). Leukemia 2005, 19:2304-2312.
23. Simpson D.R., Nevill T.J., Shepherd J.D., et al. High incidence of extramedullary relapse of AML after busulfan/cyclophosphamide conditioning and allogeneic stem cell transplantation. Bone Marrow Transplant 1998, 22:259-264.
24. Stadler M., Dierich H., Damman E., et al. Extramedullary acute leukemias prior to and after allogeneic hematopoeitic stem cell transplantation: a single-center study. ASH Annual Meeting Abstracts. Blood 2008, 112:3262.
25. Kata D., Kyrez-Krzemien S., Czerw T., et al. Incidence, treatmentand outcome of isolated extramedullary relapse after allogeneic hematopoietic stem cell transplantation for acute lymphoblastic and myeloid leukemias: single center experience with 324 patients. ASH Annual Meeting Abstracts. Blood 2008, 112:4302.
26. Porter D.L., Alyea E.P., Antin J.H., et al. NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 2011, 16:1467-1503.
27. Blum W., Penza S., Farag S., et al. Incidence of extramedullary relapse of acute myeloid leukemia following transplantation with busulfan-based conditioning regimens. ASH Annual Meeting Abstracts. Blood 2004, 104:5123.
28. Shimoni A., Rand A., Hardan I., et al. Isolated extramedullary relapse of acute leukemia after allogeneic stem cell transplantation: different kinetics and better prognosis than systemic relapse. ASH Annual Meeting Abstracts. Blood 2008, 112:2148.
29. Kobayashi M., Imamura M., Soga R., et al. Establishment of a novel granulocytic sarcoma cell line which can adhere to dermal fibroblasts from a patient with granulocytic sarcoma in dermal tissues and myelofibrosis. Br J Haematol 1992, 82:26-31.
30. Kuwabara H., Nagai M., Yamaoka G., et al. Specific skin manifestations in CD56-positive acute myeloid leukemia. J Cutan Pathol 1999, 26:1-5.
31. Ruiz-Arguelles G.J., Gomez-Almaguer D., Vela-Ojeda J., et al. Extramedullary leukemic relapses following hematopoietic stem cell transplantation with nonmyeloablative conditioning. Int J Hematol 2005, 82:262-265.
32. Chong G., Byrnes G., Szer J., et al. Extramedullary relapse after allogeneic bone marrow transplantation for haematological malignancy. Bone Marrow Transplant 2000, 26:1011-1015.
33. Sackstein R. A revision of Billingham's tenets: the central role of lymphocyte migration in acute graft-versus-host disease. Biol Blood Marrow Transplant 2006, 12(Suppl 1):2-8.
34. Byrd J.C., Edenfield W.J., Shields D.J., et al. Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review. J Clin Oncol 1995, 13:1800-1816.